Skip to main content
. 2016 Dec 2;8(1):1668–1677. doi: 10.18632/oncotarget.13774

Figure 1. Application of sunitinib and celecoxib individually or in combination inhibits the cell viability of 769-p in a dose and time dependent manner (**P < 0.01).

Figure 1